| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Bosentan |
| Brand | Tracleer® |
| Indication | Treatment pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO Functional Class (FC) III and WHO FC II. It is also indicated to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease. |
| Assessment Process | |
| Rapid review commissioned | 27/06/2014 |
| Rapid review completed | 04/07/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |
